Grants and Contributions

The main objectives of CCNA Phase III (Operations Centre and CCNA Research teams) align with and build upon Phases I and II:
• Increase the interdisciplinary collaborations within and across Teams, Themes and the Operations Centre in the area of age-related neurodegenerative diseases having an impact on cognition, including, but not limited to, prevention and risk reduction, diagnosis, treatment, care, services and social aspects;
• Build capacity in age-related neurodegenerative diseases that have an impact on cognition, including, but not limited to: prevention and risk reduction, diagnosis, treatment, care, services, social aspects, while recognizing, integrating and addressing equity, diversity and inclusion considerations, First Nations, Inuit and Métis health perspectives and persons with living/lived experience; and,
• Enhance the competitiveness of researchers in Canada, their international presence and influence on outcomes related to neurodegenerative diseases affecting cognition.

The specific objectives of the CCNA Operations Centre funding opportunity are to:
• Optimize a national operations centre to provide leadership, strengthen, and synergize innovative and collaborative Canadian research in neurodegenerative diseases;
• Provide guidance and coordination efforts for training and capacity development, to foster career development of the next generation of researchers in the field;
• Enhance the capacity for knowledge mobilization (KM) in both official languages to increase the dissemination and uptake of neurodegenerative diseases research results and enhance national and international research collaborations;
• Facilitate and support engagement of persons with neurodegenerative diseases affecting cognition and care partners to be actively involved throughout the research process;
• Scope and solidify CCNA’s strategic vision in line with the uniqueness of its data;
• Optimize systems and mechanisms ensuring increased awareness of, and responsible and timely access to CCNA data and biospecimens, while meeting ethical standards and protecting the privacy of participants; and,
• Enhance national and international research collaborations through data and KM linkages with other entities and/or research platforms, such as the CLSA.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

Funding Pool of EDL; related codes EL0-EL9

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

Funding Pool of EDL; related codes EL0-EL9

The objectives of this funding opportunity are to fund new research that will improve health and achieve more equitable outcomes in nutrition, metabolic health and chronic high burden diseases, as well as STBBI, across the life course of diverse groups of people in Canada by:

1. Developing precision medicine approaches to characterize the variability that underlies mechanisms of disease, to prevent, detect and intervene effectively in terms of disease susceptibility, progression, resilience and reversibility, and treatment
2. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health in Indigenous communities that underlie heterogeneity in health and disease
3. Increasing our understanding of interactions between structural, social, environmental, and biological determinants of health with particular emphasis on a diversity of populations who have historically experienced inequitable outcomes in Canada and at-risk groups that underlie heterogeneity in health and disease

Note that applicants will not be required to meet all the objectives in their respective application, but all objectives will be met through the funding opportunity.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of:

• Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs.

• Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions.

The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment.

As a component of Canada’s Biomanufacturing and Life Sciences Strategy, this funding opportunity shares the same objectives, namely:

• To better prepare Canada to respond to pandemics and other health emergencies; and
• To support an innovative, high growth domestic life sciences sector.